Dolby Laboratories, Inc. (DLB) stock
DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q3 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 30, 2026Score 18/305% above fair value
$63.61−0.98 (-1.52%)
Close on Nov 13, 2026Market cap $5.96BP/E 27.1Yield 2.08%
Earnings
Dolby Laboratories's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Nov 17, 2026
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$305.00M
-3.5% on a year earlier
non-GAAP, Q3 FY2026
$0.69
$0.78 a year earlier
Latest guidance
Raised
Jul 30, 2026 · 22 items
Quarterly results
Revenue and earnings per share from each of Dolby Laboratories's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Sep 26, 2026 | Nov 17, 2026Expected | – | – | – | – | – |
| Q3 FY2026ended Jun 26, 2026 | Jul 30, 2026after the close | $305.00M | -3.5% | $0.30 | $0.69 | Release |
| Q2 FY2026ended Mar 27, 2026 | Apr 30, 2026after the close | $396.00M | +7.0% | $0.99 | $1.37 | Release |
| Q1 FY2026ended Dec 26, 2025 | Jan 29, 2026after the close | $347.00M | -2.8% | $0.55 | $1.06 | Release |
| Q4 FY2025ended Sep 26, 2025 | Nov 18, 2025after the close | $307.00M | +0.7% | $0.51 | $0.99 | Release |
| Q3 FY2025ended Jun 27, 2025 | Jul 31, 2025after the close | $316.00M | +9.4% | $0.48 | $0.78 | Release |
| Q2 FY2025ended Mar 28, 2025 | May 1, 2025after the close | $370.00M | +1.5% | $0.94 | $1.34 | Release |
| Q1 FY2025ended Dec 27, 2024 | Jan 29, 2025after the close | $357.00M | +13.1% | $0.70 | $1.14 | Release |
| Q4 FY2024ended Sep 27, 2024 | Nov 19, 2024after the close | $305.00M | +5.0% | $0.61 | $0.81 | Release |
| Q3 FY2024ended Jun 28, 2024 | Aug 7, 2024after the close | $288.80M | -3.2% | $0.40 | $0.71 | Release |
| Q2 FY2024ended Mar 29, 2024 | May 2, 2024after the close | $364.50M | -3.0% | $1.01 | $1.27 | Release |
| Q1 FY2024ended Dec 29, 2023 | Feb 1, 2024after the close | $315.60M | -5.8% | – | – | Release |
| Q4 FY2023ended Sep 29, 2023 | Nov 16, 2023after the close | $290.60M | +4.5% | $0.09 | $0.65 | Release |
| Q3 FY2023ended Jun 30, 2023 | Aug 3, 2023after the close | $298.40M | +3.0% | $0.17 | $0.55 | Release |
| Q2 FY2023ended Mar 31, 2023 | May 4, 2023after the close | $375.90M | +12.4% | $0.98 | $1.26 | Release |
| Q1 FY2023ended Dec 30, 2022 | Feb 2, 2023after the close | $334.90M | -4.7% | $0.82 | $1.11 | Release |
| Q4 FY2022ended Sep 30, 2022 | Nov 17, 2022after the close | $278.20M | -2.4% | $0.28 | $0.54 | Release |
| Q3 FY2022ended Jul 1, 2022 | Aug 9, 2022after the close | $289.60M | – | $0.39 | $0.68 | Release |
| Q2 FY2022ended Apr 1, 2022 | May 5, 2022after the close | $334.40M | – | $0.36 | $0.92 | Release |
| Q1 FY2022ended Dec 31, 2021 | Feb 3, 2022after the close | $351.60M | – | $0.77 | $1.01 | Release |
| Q4 FY2021ended Sep 24, 2021 | Nov 16, 2021after the close | $285.00M | – | $0.42 | $0.58 | Release |
| Q3 FY2021ended Jun 25, 2021 | Jul 29, 2021after the close | – | – | – | – | Release |
| Q2 FY2021ended Mar 26, 2021 | May 4, 2021after the close | – | – | – | – | Release |
| Q1 FY2021ended Dec 25, 2020 | Jan 28, 2021after the close | – | – | – | – | Release |
| Q4 FY2020ended Sep 25, 2020 | Nov 12, 2020after the close | – | – | – | – | Release |
| Q3 FY2020ended Jun 26, 2020 | Aug 3, 2020after the close | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Dolby Laboratories's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total revenue | Q4 FY2026 | $362.00M – $392.00M | – | New | Jul 30, 2026 |
| Gross marginsGAAP | Q4 FY2026 | 88% | – | New | Jul 30, 2026 |
| Gross marginsnon-GAAP | Q4 FY2026 | 90% | – | New | Jul 30, 2026 |
| Diluted earnings per shareGAAP | Q4 FY2026 | $0.78 – $0.93 | – | New | Jul 30, 2026 |
| Diluted earnings per sharenon-GAAP | Q4 FY2026 | $1.13 – $1.28 | – | New | Jul 30, 2026 |
| Effective tax rateGAAP | Q4 FY2026 | 23% | – | New | Jul 30, 2026 |
| Effective tax ratenon-GAAP | Q4 FY2026 | 21% | – | New | Jul 30, 2026 |
| Licensing revenue | Q4 FY2026 | $335.00M – $365.00M | – | New | Jul 30, 2026 |
| Operating expensesGAAP | Q4 FY2026 | $227.00M – $237.00M | – | New | Jul 30, 2026 |
| Operating expensesnon-GAAP | Q4 FY2026 | $195.00M – $205.00M | – | New | Jul 30, 2026 |
| Total revenue | FY2026 | $1.41B – $1.44B | $1.40B – $1.45B | Narrowed | Jul 30, 2026 |
| Gross marginsGAAP | FY2026 | 88% | 88% | Reaffirmed | Jul 30, 2026 |
| Gross marginsnon-GAAP | FY2026 | 90% | 90% | Reaffirmed | Jul 30, 2026 |
| operating marginsGAAP | FY2026 | 21% | 21% | Reaffirmed | Jul 30, 2026 |
| operating marginsnon-GAAP | FY2026 | 34% | 34% | Reaffirmed | Jul 30, 2026 |
| Diluted earnings per shareGAAP | FY2026 | $2.62 – $2.77 | $2.66 – $2.81 | Lowered | Jul 30, 2026 |
| Diluted earnings per sharenon-GAAP | FY2026 | $4.25 – $4.40 | $4.30 – $4.45 | Lowered | Jul 30, 2026 |
| Effective tax rateGAAP | FY2026 | 24% | 23% | Raised | Jul 30, 2026 |
| Effective tax ratenon-GAAP | FY2026 | 21% | 20% | Raised | Jul 30, 2026 |
| Licensing revenue | FY2026 | $1.31B – $1.34B | $1.30B – $1.35B | Narrowed | Jul 30, 2026 |
| Operating expensesGAAP | FY2026 | $937.00M – $947.00M | $930.00M – $950.00M | Narrowed | Jul 30, 2026 |
| Operating expensesnon-GAAP | FY2026 | $785.00M – $795.00M | $780.00M – $800.00M | Narrowed | Jul 30, 2026 |
Guidance vs results
The last range Dolby Laboratories gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | Diluted earnings per share | $0.56 – $0.71 | $0.69 | Within range |
| Q3 FY2026 | EPS (GAAP) | $0.19 – $0.34 | $0.30 | Within range |
| Q3 FY2026 | Revenue | $295.00M – $325.00M | $305.00M | Within range |
| Q2 FY2026 | Diluted earnings per share | $1.29 – $1.44 | $1.37 | Within range |
| Q2 FY2026 | EPS (GAAP) | $0.94 – $1.09 | $0.99 | Within range |
| Q2 FY2026 | Revenue | $375.00M – $405.00M | $396.00M | Within range |
| Q1 FY2026 | Diluted earnings per share | $0.79 – $0.94 | $1.06 | Above range |
| Q1 FY2026 | EPS (GAAP) | $0.39 – $0.54 | $0.55 | Above range |
| Q1 FY2026 | Revenue | $315.00M – $345.00M | $347.00M | Above range |
| FY2025 | Diluted earnings per share | $3.88 – $4.03 | $4.25Σ4Q | Above range |
| FY2025 | EPS (GAAP) | $2.40 – $2.55 | $2.63Σ4Q | Above range |
| FY2025 | Revenue | $1.33B – $1.36B | $1.35BΣ4Q | Within range |
| Q4 FY2025 | Diluted earnings per share | $0.61 – $0.76 | $0.99 | Above range |
| Q4 FY2025 | EPS (GAAP) | $0.28 – $0.43 | $0.51 | Above range |
| Q4 FY2025 | Revenue | $288.00M – $318.00M | $307.00M | Within range |
| Q3 FY2025 | Diluted earnings per share | $0.62 – $0.77 | $0.78 | Above range |
| Q3 FY2025 | EPS (GAAP) | $0.26 – $0.41 | $0.48 | Above range |
| Q3 FY2025 | Revenue | $290.00M – $320.00M | $316.00M | Within range |
| Q2 FY2025 | Diluted earnings per share | $1.19 – $1.34 | $1.34 | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.77 – $0.92 | $0.94 | Above range |
| Q2 FY2025 | Revenue | $355.00M – $385.00M | $370.00M | Within range |
| Q1 FY2025 | Diluted earnings per share | $0.96 – $1.11 | $1.14 | Above range |
| Q1 FY2025 | EPS (GAAP) | $0.53 – $0.68 | $0.70 | Above range |
| Q1 FY2025 | Revenue | $330.00M – $360.00M | $357.00M | Within range |
| Q4 FY2024 | Diluted earnings per share | $0.61 – $0.76 | $0.81 | Above range |
| Q4 FY2024 | EPS (GAAP) | $0.31 – $0.46 | $0.61 | Above range |
| Q4 FY2024 | Revenue | $300.00M – $320.00M | $305.00M | Within range |
| Q3 FY2024 | Diluted earnings per share | $0.51 – $0.66 | $0.71 | Above range |
| Q3 FY2024 | EPS (GAAP) | $0.21 – $0.36 | $0.40 | Above range |
| Q3 FY2024 | Revenue | $270.00M – $300.00M | $288.80M | Within range |
| Q2 FY2024 | Revenue | $345.00M – $375.00M | $364.50M | Within range |
| Q1 FY2024 | Revenue | $300.00M – $330.00M | $315.60M | Within range |
| Q4 FY2023 | Diluted earnings per share | $0.40 – $0.60 | $0.65 | Above range |
| Q4 FY2023 | EPS (GAAP) | $0.10 – $0.30 | $0.09 | Below range |
| Q4 FY2023 | Revenue | $275.00M – $305.00M | $290.60M | Within range |
| Q3 FY2023 | Diluted earnings per share | $0.47 – $0.62 | $0.55 | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.18 – $0.33 | $0.17 | Below range |
| Q3 FY2023 | Revenue | $285.00M – $315.00M | $298.40M | Within range |
| Q2 FY2023 | Diluted earnings per share | $0.90 – $1.05 | $1.26 | Above range |
| Q2 FY2023 | EPS (GAAP) | $0.58 – $0.73 | $0.98 | Above range |
| Q2 FY2023 | Revenue | $340.00M – $370.00M | $375.90M | Above range |
| Q1 FY2023 | Diluted earnings per share | $0.76 – $0.91 | $1.11 | Above range |
| Q1 FY2023 | EPS (GAAP) | $0.46 – $0.61 | $0.82 | Above range |
| Q1 FY2023 | Revenue | $300.00M – $330.00M | $334.90M | Above range |
| Q4 FY2022 | Diluted earnings per share | $0.68 – $0.83 | $0.54 | Below range |
| Q4 FY2022 | EPS (GAAP) | $0.40 – $0.55 | $0.28 | Below range |
| Q4 FY2022 | Revenue | $295.00M – $325.00M | $278.20M | Below range |
| Q3 FY2022 | Diluted earnings per share | $0.54 – $0.69 | $0.68 | Within range |
| Q3 FY2022 | EPS (GAAP) | $0.28 – $0.43 | $0.39 | Within range |
| Q3 FY2022 | Revenue | $285.00M – $310.00M | $289.60M | Within range |
| Q2 FY2022 | Diluted earnings per share | $0.72 – $0.87 | $0.92 | Above range |
| Q2 FY2022 | EPS (GAAP) | $0.42 – $0.57 | $0.36 | Below range |
| Q2 FY2022 | Revenue | $315.00M – $345.00M | $334.40M | Within range |
| Q1 FY2022 | Diluted earnings per share | $0.98 – $1.13 | $1.01 | Within range |
| Q1 FY2022 | EPS (GAAP) | $0.71 – $0.86 | $0.77 | Within range |
| Q1 FY2022 | Revenue | $345.00M – $375.00M | $351.60M | Within range |
Guidance history
Every forecast Dolby Laboratories put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Jul 30, 2026 | Diluted earnings per share | FY2026 | $4.25 – $4.40 | Lowered |
| Jul 30, 2026 | Diluted earnings per share | Q4 FY2026 | $1.13 – $1.28 | New |
| Jul 30, 2026 | Diluted earnings per share | FY2026 | $2.62 – $2.77 | Lowered |
| Jul 30, 2026 | Diluted earnings per share | Q4 FY2026 | $0.78 – $0.93 | New |
| Jul 30, 2026 | Gross margins | FY2026 | 88% | Reaffirmed |
| Jul 30, 2026 | Gross margins | FY2026 | 90% | Reaffirmed |
| Jul 30, 2026 | Gross margins | Q4 FY2026 | 88% | New |
| Jul 30, 2026 | Gross margins | Q4 FY2026 | 90% | New |
| Jul 30, 2026 | operating margins | FY2026 | 21% | Reaffirmed |
| Jul 30, 2026 | operating margins | FY2026 | 34% | Reaffirmed |
| Jul 30, 2026 | Effective tax rate | FY2026 | 24% | Raised |
| Jul 30, 2026 | Effective tax rate | FY2026 | 21% | Raised |
| Jul 30, 2026 | Licensing revenue | FY2026 | $1.31B – $1.34B | Narrowed |
| Jul 30, 2026 | Operating expenses | FY2026 | $937.00M – $947.00M | Narrowed |
| Jul 30, 2026 | Operating expenses | FY2026 | $785.00M – $795.00M | Narrowed |
| Jul 30, 2026 | Effective tax rate | Q4 FY2026 | 23% | New |
| Jul 30, 2026 | Effective tax rate | Q4 FY2026 | 21% | New |
| Jul 30, 2026 | Licensing revenue | Q4 FY2026 | $335.00M – $365.00M | New |
| Jul 30, 2026 | Operating expenses | Q4 FY2026 | $227.00M – $237.00M | New |
| Jul 30, 2026 | Operating expenses | Q4 FY2026 | $195.00M – $205.00M | New |
| Jul 30, 2026 | Total revenue | FY2026 | $1.41B – $1.44B | Narrowed |
| Jul 30, 2026 | Total revenue | Q4 FY2026 | $362.00M – $392.00M | New |
| Apr 30, 2026 | Diluted earnings per share | FY2026 | $4.30 – $4.45 | Reaffirmed |
| Apr 30, 2026 | Diluted earnings per share | Q3 FY2026 | $0.56 – $0.71 | New |
| Apr 30, 2026 | Diluted earnings per share | FY2026 | $2.66 – $2.81 | Lowered |
| Apr 30, 2026 | Diluted earnings per share | Q3 FY2026 | $0.19 – $0.34 | New |
| Apr 30, 2026 | Gross margins | Q3 FY2026 | 88% | New |
| Apr 30, 2026 | Gross margins | FY2026 | 90% | Reaffirmed |
| Apr 30, 2026 | Gross margins | Q3 FY2026 | 86% | New |
| Apr 30, 2026 | Gross margins | FY2026 | 88% | Reaffirmed |
| Apr 30, 2026 | operating margins | FY2026 | 21% | Reaffirmed |
| Apr 30, 2026 | operating margins | FY2026 | 34% | Reaffirmed |
| Apr 30, 2026 | Operating expenses | Q3 FY2026 | $235.00M – $245.00M | New |
| Apr 30, 2026 | Operating expenses | Q3 FY2026 | $200.00M – $210.00M | New |
| Apr 30, 2026 | Licensing revenue | FY2026 | $1.30B – $1.35B | Raised |
| Apr 30, 2026 | Effective tax rate | FY2026 | 23% | Reaffirmed |
| Apr 30, 2026 | Effective tax rate | FY2026 | 20% | Lowered |
| Apr 30, 2026 | Operating expenses | FY2026 | $930.00M – $950.00M | Reaffirmed |
| Apr 30, 2026 | Operating expenses | FY2026 | $780.00M – $800.00M | Reaffirmed |
| Apr 30, 2026 | Effective tax rate | Q3 FY2026 | 23% | New |
| Apr 30, 2026 | Effective tax rate | Q3 FY2026 | 21% | New |
| Apr 30, 2026 | Licensing revenue | Q3 FY2026 | $270.00M – $300.00M | New |
| Apr 30, 2026 | Total revenue | Q3 FY2026 | $295.00M – $325.00M | New |
| Apr 30, 2026 | Total revenue | FY2026 | $1.40B – $1.45B | Raised |
| Jan 29, 2026 | Diluted earnings per share | FY2026 | $4.30 – $4.45 | Raised |
| Jan 29, 2026 | Diluted earnings per share | Q2 FY2026 | $1.29 – $1.44 | New |
| Jan 29, 2026 | Diluted earnings per share | FY2026 | $2.71 – $2.86 | Raised |
| Jan 29, 2026 | Diluted earnings per share | Q2 FY2026 | $0.94 – $1.09 | New |
| Jan 29, 2026 | Gross margins | FY2026 | 88% | Reaffirmed |
| Jan 29, 2026 | Gross margins | FY2026 | 90% | Reaffirmed |
| Jan 29, 2026 | Gross margins | Q2 FY2026 | 90% | New |
| Jan 29, 2026 | Gross margins | Q2 FY2026 | 91% | New |
| Jan 29, 2026 | operating margins | FY2026 | 21% | Reaffirmed |
| Jan 29, 2026 | operating margins | FY2026 | 34% | Reaffirmed |
| Jan 29, 2026 | Effective tax rate | FY2026 | 23% | Reaffirmed |
| Jan 29, 2026 | Effective tax rate | FY2026 | 21% | Reaffirmed |
| Jan 29, 2026 | Operating expenses | FY2026 | $930.00M – $950.00M | Reaffirmed |
| Jan 29, 2026 | Operating expenses | FY2026 | $780.00M – $800.00M | Reaffirmed |
| Jan 29, 2026 | Effective tax rate | Q2 FY2026 | 23% | New |
| Jan 29, 2026 | Effective tax rate | Q2 FY2026 | 21% | New |
| Jan 29, 2026 | Operating expenses | Q2 FY2026 | $230.00M – $240.00M | New |
| Jan 29, 2026 | Operating expenses | Q2 FY2026 | $195.00M – $205.00M | New |
| Jan 29, 2026 | Total revenue | FY2026 | $1.40B – $1.45B | Raised |
| Jan 29, 2026 | Licensing revenue | FY2026 | $1.30B – $1.35B | Lowered |
| Jan 29, 2026 | Total revenue | Q2 FY2026 | $375.00M – $405.00M | New |
| Jan 29, 2026 | Licensing revenue | Q2 FY2026 | $350.00M – $380.00M | Lowered |
| Nov 18, 2025 | Diluted earnings per share | FY2026 | $4.19 – $4.34 | New |
| Nov 18, 2025 | Diluted earnings per share | Q1 FY2026 | $0.79 – $0.94 | New |
| Nov 18, 2025 | Diluted earnings per share | FY2026 | $2.61 – $2.76 | New |
| Nov 18, 2025 | Diluted earnings per share | Q1 FY2026 | $0.39 – $0.54 | New |
| Nov 18, 2025 | Gross margins | FY2026 | 88% | New |
| Nov 18, 2025 | Gross margins | FY2026 | 90% | New |
| Nov 18, 2025 | Gross margins | Q1 FY2026 | 88% | New |
| Nov 18, 2025 | Gross margins | Q1 FY2026 | 90% | New |
| Nov 18, 2025 | operating margins | FY2026 | 21% | New |
| Nov 18, 2025 | operating margins | FY2026 | 34% | New |
| Nov 18, 2025 | Effective tax rate | FY2026 | 23% | New |
| Nov 18, 2025 | Effective tax rate | FY2026 | 21% | New |
| Nov 18, 2025 | Licensing revenue | FY2026 | $1.29B – $1.34B | New |
| Nov 18, 2025 | Operating expenses | FY2026 | $930.00M – $950.00M | New |
| Nov 18, 2025 | Operating expenses | FY2026 | $780.00M – $800.00M | New |
| Nov 18, 2025 | Effective tax rate | Q1 FY2026 | 23% | New |
| Nov 18, 2025 | Effective tax rate | Q1 FY2026 | 21% | New |
| Nov 18, 2025 | Licensing revenue | Q1 FY2026 | $290.00M – $320.00M | New |
| Nov 18, 2025 | Operating expenses | Q1 FY2026 | $235.00M – $245.00M | New |
| Nov 18, 2025 | Operating expenses | Q1 FY2026 | $195.00M – $205.00M | New |
| Nov 18, 2025 | Total revenue | FY2026 | $1.39B – $1.44B | New |
| Nov 18, 2025 | Total revenue | Q1 FY2026 | $315.00M – $345.00M | New |
| Jul 31, 2025 | Diluted earnings per share | FY2025 | $3.88 – $4.03 | New |
| Jul 31, 2025 | Diluted earnings per share | Q4 FY2025 | $0.61 – $0.76 | New |
| Jul 31, 2025 | Diluted earnings per share | FY2025 | $2.40 – $2.55 | New |
| Jul 31, 2025 | Diluted earnings per share | Q4 FY2025 | $0.28 – $0.43 | New |
| Jul 31, 2025 | Gross margins | FY2025 | 88% | New |
| Jul 31, 2025 | Gross margins | FY2025 | 90% | New |
| Jul 31, 2025 | Gross margins | Q4 FY2025 | 86% | New |
| Jul 31, 2025 | Gross margins | Q4 FY2025 | 88% | New |
| Jul 31, 2025 | operating margins | FY2025 | 20% | New |
| Jul 31, 2025 | operating margins | FY2025 | 33% | New |
| Jul 31, 2025 | Effective tax rate | FY2025 | 21.5% | New |
| Jul 31, 2025 | Effective tax rate | FY2025 | 20% | New |
| Jul 31, 2025 | Licensing revenue | FY2025 | $1.23B – $1.26B | New |
| Jul 31, 2025 | Operating expenses | FY2025 | $910.00M – $920.00M | New |
| Jul 31, 2025 | Operating expenses | FY2025 | $765.00M – $775.00M | New |
| Jul 31, 2025 | Effective tax rate | Q4 FY2025 | 24.5% | New |
| Jul 31, 2025 | Effective tax rate | Q4 FY2025 | 21% | New |
| Jul 31, 2025 | Licensing revenue | Q4 FY2025 | $263.00M – $293.00M | New |
| Jul 31, 2025 | Operating expenses | Q4 FY2025 | $225.00M – $235.00M | New |
| Jul 31, 2025 | Operating expenses | Q4 FY2025 | $190.00M – $200.00M | New |
| Jul 31, 2025 | Total revenue | FY2025 | $1.33B – $1.36B | New |
| Jul 31, 2025 | Total revenue | Q4 FY2025 | $288.00M – $318.00M | New |
| May 1, 2025 | Diluted earnings per share | Q3 FY2025 | $0.62 – $0.77 | New |
| May 1, 2025 | Diluted earnings per share | FY2025 | $3.88 – $4.03 | Lowered |
| May 1, 2025 | Diluted earnings per share | Q3 FY2025 | $0.26 – $0.41 | New |
| May 1, 2025 | Diluted earnings per share | FY2025 | $2.31 – $2.46 | Lowered |
| May 1, 2025 | Gross margins | Q3 FY2025 | 86% | New |
| May 1, 2025 | Gross margins | Q3 FY2025 | 88% | New |
| May 1, 2025 | Gross margins | FY2025 | 87% | Reaffirmed |
| May 1, 2025 | Gross margins | FY2025 | 90% | Reaffirmed |
| May 1, 2025 | operating margins | FY2025 | 33% | Reaffirmed |
| May 1, 2025 | operating margins | FY2025 | 20% | Reaffirmed |
| May 1, 2025 | Effective tax rate | Q3 FY2025 | 23% | New |
| May 1, 2025 | Effective tax rate | Q3 FY2025 | 20.5% | New |
| May 1, 2025 | Operating expenses | Q3 FY2025 | $225.00M – $235.00M | New |
| May 1, 2025 | Operating expenses | Q3 FY2025 | $190.00M – $200.00M | New |
| May 1, 2025 | Effective tax rate | FY2025 | 20% | New |
| May 1, 2025 | Operating expenses | FY2025 | $905.00M – $920.00M | Lowered |
| May 1, 2025 | Operating expenses | FY2025 | $760.00M – $775.00M | Lowered |
| May 1, 2025 | Effective tax rate | FY2025 | 22.5% | New |
| May 1, 2025 | Total revenue | FY2025 | $1.31B – $1.38B | Raised |
| May 1, 2025 | Total revenue | Q3 FY2025 | $290.00M – $320.00M | New |
| May 1, 2025 | Licensing revenue | Q3 FY2025 | $265.00M – $295.00M | Lowered |
| May 1, 2025 | Licensing revenue | FY2025 | $1.21B – $1.28B | Lowered |
| Jan 29, 2025 | Diluted earnings per share | Q2 FY2025 | $1.19 – $1.34 | New |
| Jan 29, 2025 | Diluted earnings per share | FY2025 | $3.99 – $4.14 | Reaffirmed |
| Jan 29, 2025 | Diluted earnings per share | Q2 FY2025 | $0.77 – $0.92 | New |
| Jan 29, 2025 | Diluted earnings per share | FY2025 | $2.39 – $2.54 | Lowered |
| Jan 29, 2025 | Gross margins | FY2025 | 90% | Reaffirmed |
| Jan 29, 2025 | Gross margins | Q2 FY2025 | 89% | New |
| Jan 29, 2025 | Gross margins | Q2 FY2025 | 91% | New |
| Jan 29, 2025 | Gross margins | FY2025 | 87% | Reaffirmed |
| Jan 29, 2025 | operating margins | FY2025 | 20% | Reaffirmed |
| Jan 29, 2025 | operating margins | FY2025 | 33% | Reaffirmed |
| Jan 29, 2025 | Effective tax rate | Q2 FY2025 | 20.5% | New |
| Jan 29, 2025 | Effective tax rate | Q2 FY2025 | 18.5% | New |
| Jan 29, 2025 | Operating expenses | Q2 FY2025 | $230.00M – $240.00M | New |
| Jan 29, 2025 | Operating expenses | Q2 FY2025 | $190.00M – $200.00M | New |
| Jan 29, 2025 | Operating expenses | FY2025 | $915.00M – $925.00M | Raised |
| Jan 29, 2025 | Operating expenses | FY2025 | $765.00M – $775.00M | Reaffirmed |
| Jan 29, 2025 | Licensing revenue | FY2025 | $1.22B – $1.28B | Lowered |
| Jan 29, 2025 | Total revenue | Q2 FY2025 | $355.00M – $385.00M | New |
| Jan 29, 2025 | Licensing revenue | Q2 FY2025 | $330.00M – $360.00M | Lowered |
| Jan 29, 2025 | Total revenue | FY2025 | $1.33B – $1.39B | Reaffirmed |
| Nov 19, 2024 | Diluted earnings per share | FY2025 | $3.99 – $4.14 | New |
| Nov 19, 2024 | Diluted earnings per share | Q1 FY2025 | $0.96 – $1.11 | New |
| Nov 19, 2024 | Diluted earnings per share | FY2025 | $2.43 – $2.58 | New |
| Nov 19, 2024 | Diluted earnings per share | Q1 FY2025 | $0.53 – $0.68 | New |
| Nov 19, 2024 | Gross margins | FY2025 | 87% | New |
| Nov 19, 2024 | Gross margins | Q1 FY2025 | 90% | New |
| Nov 19, 2024 | Gross margins | FY2025 | 90% | New |
| Nov 19, 2024 | Gross margins | Q1 FY2025 | 87% | New |
| Nov 19, 2024 | operating margins | FY2025 | 20% | New |
| Nov 19, 2024 | operating margins | FY2025 | 33% | New |
| Nov 19, 2024 | Operating expenses | FY2025 | $765.00M – $775.00M | New |
| Nov 19, 2024 | Operating expenses | Q1 FY2025 | $230.00M – $240.00M | New |
| Nov 19, 2024 | Operating expenses | Q1 FY2025 | $190.00M – $200.00M | New |
| Nov 19, 2024 | Operating expenses | FY2025 | $908.00M – $918.00M | New |
| Nov 19, 2024 | Effective tax rate | Q1 FY2025 | 20.5% | New |
| Nov 19, 2024 | Effective tax rate | Q1 FY2025 | 18.5% | New |
| Nov 19, 2024 | Total revenue | Q1 FY2025 | $330.00M – $360.00M | New |
| Nov 19, 2024 | Licensing revenue | Q1 FY2025 | $305.00M – $335.00M | Lowered |
| Nov 19, 2024 | Total revenue | FY2025 | $1.33B – $1.39B | New |
| Aug 7, 2024 | Diluted earnings per share | Q4 FY2024 | $0.61 – $0.76 | New |
| Aug 7, 2024 | Diluted earnings per share | FY2024 | $3.60 – $3.75 | Reaffirmed |
| Aug 7, 2024 | Diluted earnings per share | Q4 FY2024 | $0.31 – $0.46 | New |
| Aug 7, 2024 | Diluted earnings per share | FY2024 | $2.40 – $2.55 | Raised |
| Aug 7, 2024 | Gross margins | FY2024 | 89% | Reaffirmed |
| Aug 7, 2024 | Gross margins | Q4 FY2024 | 88% | New |
| Aug 7, 2024 | operating margins | FY2024 | 20% | Reaffirmed |
| Aug 7, 2024 | operating margins | FY2024 | 31% | Lowered |
| Aug 7, 2024 | Operating expenses | FY2024 | $735.00M – $745.00M | Lowered |
| Aug 7, 2024 | Operating expenses | Q4 FY2024 | $190.00M – $200.00M | New |
| Aug 7, 2024 | Operating expenses | FY2024 | $875.00M – $885.00M | Lowered |
| Aug 7, 2024 | Effective tax rate | Q4 FY2024 | 29% | New |
| Aug 7, 2024 | Effective tax rate | Q4 FY2024 | 23% | New |
| Aug 7, 2024 | Licensing revenue | Q4 FY2024 | $275.00M – $295.00M | New |
| Aug 7, 2024 | Operating expenses | Q4 FY2024 | $225.00M – $235.00M | New |
| Aug 7, 2024 | Total revenue | Q4 FY2024 | $300.00M – $320.00M | New |
| Aug 7, 2024 | Total revenue | FY2024 | $1.27B – $1.29B | Lowered |
| May 2, 2024 | Diluted earnings per share | FY2024 | $3.60 – $3.75 | Reaffirmed |
| May 2, 2024 | Diluted earnings per share | Q3 FY2024 | $0.51 – $0.66 | New |
| May 2, 2024 | Diluted earnings per share | Q3 FY2024 | $0.21 – $0.36 | New |
| May 2, 2024 | Diluted earnings per share | FY2024 | $2.30 – $2.45 | Reaffirmed |
| May 2, 2024 | Gross margins | FY2024 | 89% | Reaffirmed |
| May 2, 2024 | Gross margins | Q3 FY2024 | 87% | New |
| May 2, 2024 | operating margins | FY2024 | 20% | Reaffirmed |
| May 2, 2024 | operating margins | FY2024 | 32% | Reaffirmed |
| May 2, 2024 | Operating expenses | FY2024 | $740.00M – $750.00M | Reaffirmed |
| May 2, 2024 | Operating expenses | Q3 FY2024 | $180.00M – $190.00M | New |
| May 2, 2024 | Operating expenses | FY2024 | $885.00M – $895.00M | Reaffirmed |
| May 2, 2024 | Effective tax rate | Q3 FY2024 | 24% | New |
| May 2, 2024 | Effective tax rate | Q3 FY2024 | 21% | New |
| May 2, 2024 | Licensing revenue | Q3 FY2024 | $245.00M – $275.00M | New |
| May 2, 2024 | Operating expenses | Q3 FY2024 | $215.00M – $225.00M | New |
| May 2, 2024 | Total revenue | Q3 FY2024 | $270.00M – $300.00M | New |
| May 2, 2024 | Total revenue | FY2024 | $1.30B | Reaffirmed |
| Feb 1, 2024 | Gross margins | Q2 FY2024 | 90% | New |
| Feb 1, 2024 | Gross margins | FY2024 | 89% | Reaffirmed |
| Feb 1, 2024 | Effective tax rate | Q2 FY2024 | 23% | New |
| Feb 1, 2024 | Effective tax rate | Q2 FY2024 | 20% | New |
| Feb 1, 2024 | Total revenue | Q2 FY2024 | $345.00M – $375.00M | New |
| Feb 1, 2024 | Total revenue | FY2024 | $1.30B | Reaffirmed |
| Nov 16, 2023 | Diluted earnings per share | Q1 FY2024 | $0.80 – $0.95 | New |
| Nov 16, 2023 | Diluted earnings per share | FY2024 | $3.60 – $3.75 | New |
| Nov 16, 2023 | Diluted earnings per share | FY2024 | $2.30 – $2.45 | New |
| Nov 16, 2023 | Diluted earnings per share | Q1 FY2024 | $0.44 – $0.59 | New |
| Nov 16, 2023 | Gross margins | Q1 FY2024 | 89% – 90% | New |
| Nov 16, 2023 | Gross margins | FY2024 | 89% | New |
| Nov 16, 2023 | operating margins | FY2024 | 32% | New |
| Nov 16, 2023 | operating margins | FY2024 | 20% | New |
| Nov 16, 2023 | Operating expenses | FY2024 | $885.00M – $895.00M | New |
| Nov 16, 2023 | Effective tax rate | Q1 FY2024 | 23% | New |
| Nov 16, 2023 | Effective tax rate | Q1 FY2024 | 20% | New |
| Nov 16, 2023 | Operating expenses | Q1 FY2024 | $220.00M – $230.00M | New |
| Nov 16, 2023 | Operating expenses | Q1 FY2024 | $180.00M – $190.00M | New |
| Nov 16, 2023 | Operating expenses | FY2024 | $740.00M – $750.00M | New |
| Nov 16, 2023 | Total revenue | Q1 FY2024 | $300.00M – $330.00M | New |
| Nov 16, 2023 | Total revenue | FY2024 | $1.30B | New |
| Aug 3, 2023 | Diluted earnings per share | Q4 FY2023 | $0.40 – $0.60 | New |
| Aug 3, 2023 | Diluted earnings per share | FY2023 | $3.30 – $3.50 | Narrowed |
| Aug 3, 2023 | Diluted earnings per share | Q4 FY2023 | $0.10 – $0.30 | New |
| Aug 3, 2023 | Diluted earnings per share | FY2023 | $2.10 – $2.30 | Narrowed |
| Aug 3, 2023 | Gross margins | FY2023 | 87.5% | Lowered |
| Aug 3, 2023 | Gross margins | Q4 FY2023 | 86.5% | New |
| Aug 3, 2023 | Gross margins | Q4 FY2023 | 87.5% | New |
| Aug 3, 2023 | Gross margins | FY2023 | 88% | Reaffirmed |
| Aug 3, 2023 | operating margins | FY2023 | 30% | Reaffirmed |
| Aug 3, 2023 | operating margins | FY2023 | 18% | Lowered |
| Aug 3, 2023 | Effective tax rate | Q4 FY2023 | 22% – 24% | New |
| Aug 3, 2023 | Operating expenses | FY2023 | $760.00M – $770.00M | New |
| Aug 3, 2023 | Effective tax rate | Q4 FY2023 | 19% – 21% | New |
| Aug 3, 2023 | Operating expenses | Q4 FY2023 | $195.00M – $205.00M | New |
| Aug 3, 2023 | Operating expenses | FY2023 | $900.00M – $910.00M | New |
| Aug 3, 2023 | Operating expenses | Q4 FY2023 | $227.00M – $237.00M | New |
| Aug 3, 2023 | Total revenue | FY2023 | $1.29B – $1.32B | Narrowed |
| Aug 3, 2023 | Total revenue | Q4 FY2023 | $275.00M – $305.00M | New |
| May 4, 2023 | Diluted earnings per share | Q3 FY2023 | $0.47 – $0.62 | New |
| May 4, 2023 | Diluted earnings per share | FY2023 | $3.15 – $3.65 | New |
| May 4, 2023 | Diluted earnings per share | Q3 FY2023 | $0.18 – $0.33 | New |
| May 4, 2023 | Diluted earnings per share | FY2023 | $2.01 – $2.51 | New |
| May 4, 2023 | Gross margin percentages | FY2023 | 88% | New |
| May 4, 2023 | Gross margin percentages | Q3 FY2023 | 86% – 87% | New |
| May 4, 2023 | Gross margin percentages | FY2023 | 88% | New |
| May 4, 2023 | Gross margin percentages | Q3 FY2023 | 86% | New |
| May 4, 2023 | operating margins | FY2023 | 30% | Reaffirmed |
| May 4, 2023 | operating margins | FY2023 | 19% | Reaffirmed |
| May 4, 2023 | Operating expenses | Q3 FY2023 | $195.00M – $205.00M | New |
| May 4, 2023 | Non-GAAP operating expenses | FY2023 | +2% | Reaffirmed |
| May 4, 2023 | Effective tax rate | Q3 FY2023 | 22% – 24% | New |
| May 4, 2023 | Effective tax rate | Q3 FY2023 | 19% – 21% | New |
| May 4, 2023 | Operating expenses | Q3 FY2023 | $227.00M – $237.00M | New |
| May 4, 2023 | GAAP operating expenses | FY2023 | -2% | Reaffirmed |
| May 4, 2023 | Total revenue | FY2023 | $1.27B – $1.33B | New |
| May 4, 2023 | Total revenue | Q3 FY2023 | $285.00M – $315.00M | New |
| Feb 2, 2023 | Diluted earnings per share | Q2 FY2023 | $0.90 – $1.05 | New |
| Feb 2, 2023 | Diluted earnings per share | Q2 FY2023 | $0.58 – $0.73 | New |
| Feb 2, 2023 | operating margins | FY2023 | 30% | Reaffirmed |
| Feb 2, 2023 | operating margins | FY2023 | 19% | Reaffirmed |
| Feb 2, 2023 | Effective tax rate | Q2 FY2023 | 19% – 21% | New |
| Feb 2, 2023 | Operating expenses | Q2 FY2023 | $227.00M – $237.00M | New |
| Feb 2, 2023 | Operating expenses | Q2 FY2023 | $193.00M – $203.00M | New |
| Feb 2, 2023 | GAAP operating expenses | FY2023 | -2% | Reaffirmed |
| Feb 2, 2023 | Non-GAAP operating expenses | FY2023 | +2% | Reaffirmed |
| Feb 2, 2023 | Effective tax rate | Q2 FY2023 | 22% – 24% | New |
| Feb 2, 2023 | Total revenue | Q2 FY2023 | $340.00M – $370.00M | New |
| Nov 17, 2022 | Diluted earnings per share | Q1 FY2023 | $0.76 – $0.91 | New |
| Nov 17, 2022 | Diluted earnings per share | Q1 FY2023 | $0.46 – $0.61 | New |
| Nov 17, 2022 | operating margins | FY2023 | 30% | New |
| Nov 17, 2022 | operating margins | FY2023 | 19% | New |
| Nov 17, 2022 | Operating expenses | Q1 FY2023 | $214.00M – $224.00M | New |
| Nov 17, 2022 | Operating expenses | Q1 FY2023 | $180.00M – $190.00M | New |
| Nov 17, 2022 | GAAP operating expenses | FY2023 | -2% | New |
| Nov 17, 2022 | Non-GAAP operating expenses | FY2023 | +2% | New |
| Nov 17, 2022 | Effective tax rate | Q1 FY2023 | 22% – 24% | New |
| Nov 17, 2022 | Effective tax rate | Q1 FY2023 | 19% – 21% | New |
| Nov 17, 2022 | Total revenue | Q1 FY2023 | $300.00M – $330.00M | New |
| Aug 9, 2022 | Diluted earnings per share | Q4 FY2022 | $0.68 – $0.83 | New |
| Aug 9, 2022 | Diluted earnings per share | FY2022 | $3.22 – $3.37 | Lowered |
| Aug 9, 2022 | Diluted earnings per share | Q4 FY2022 | $0.40 – $0.55 | New |
| Aug 9, 2022 | Diluted earnings per share | FY2022 | $1.91 – $2.06 | Lowered |
| Aug 9, 2022 | Gross margin percentages | FY2022 | 89% – 90% | New |
| Aug 9, 2022 | Gross margin percentages | FY2022 | 88.5% – 89.5% | New |
| Aug 9, 2022 | Operating margin percentages | FY2022 | 17% – 19% | Lowered |
| Aug 9, 2022 | Operating margin percentages | FY2022 | 30% – 32% | Lowered |
| Aug 9, 2022 | Effective tax rate | Q4 FY2022 | 21% – 22% | New |
| Aug 9, 2022 | Operating expenses | FY2022 | $901.00M – $911.00M | Lowered |
| Aug 9, 2022 | Operating expenses | FY2022 | $740.00M – $750.00M | Lowered |
| Aug 9, 2022 | Effective tax rate | Q4 FY2022 | 18% – 19% | New |
| Aug 9, 2022 | Operating expenses | Q4 FY2022 | $210.00M – $220.00M | New |
| Aug 9, 2022 | Operating expenses | Q4 FY2022 | $180.00M – $190.00M | New |
| Aug 9, 2022 | Effective tax rate | FY2022 | 16% – 17% | Lowered |
| Aug 9, 2022 | Effective tax rate | FY2022 | 17% – 18% | Lowered |
| Aug 9, 2022 | Total revenue | FY2022 | $1.27B – $1.30B | Lowered |
| Aug 9, 2022 | Total revenue | Q4 FY2022 | $295.00M – $325.00M | New |
| May 5, 2022 | Diluted earnings per share | Q3 FY2022 | $0.54 – $0.69 | New |
| May 5, 2022 | Diluted earnings per share | FY2022 | $3.27 – $3.77 | Lowered |
| May 5, 2022 | Diluted earnings per share | Q3 FY2022 | $0.28 – $0.43 | New |
| May 5, 2022 | Diluted earnings per share | FY2022 | $1.98 – $2.48 | Lowered |
| May 5, 2022 | Gross margin percentages | Q3 FY2022 | 88.5% – 89.5% | New |
| May 5, 2022 | Gross margin percentages | Q3 FY2022 | 89% – 90% | New |
| May 5, 2022 | Operating margin percentages | FY2022 | 19% – 21% | Lowered |
| May 5, 2022 | Operating margin percentages | FY2022 | 32% – 34% | Lowered |
| May 5, 2022 | Operating expenses | FY2022 | $905.00M – $925.00M | Raised |
| May 5, 2022 | Effective tax rate | Q3 FY2022 | 19% – 20% | New |
| May 5, 2022 | Effective tax rate | Q3 FY2022 | 18% – 19% | New |
| May 5, 2022 | Operating expenses | Q3 FY2022 | $214.00M – $224.00M | New |
| May 5, 2022 | Operating expenses | Q3 FY2022 | $185.00M – $195.00M | New |
| May 5, 2022 | Effective tax rate | FY2022 | 16% – 18% | New |
| May 5, 2022 | Effective tax rate | FY2022 | 17% – 19% | New |
| May 5, 2022 | Operating expenses | FY2022 | $745.00M – $765.00M | Lowered |
| May 5, 2022 | Total revenue | Q3 FY2022 | $285.00M – $310.00M | New |
| May 5, 2022 | Total revenue | FY2022 | $1.30B – $1.35B | Lowered |
| Feb 3, 2022 | Diluted earnings per share | Q2 FY2022 | $0.72 – $0.87 | New |
| Feb 3, 2022 | Diluted earnings per share | FY2022 | $3.52 – $4.02 | Reaffirmed |
| Feb 3, 2022 | Diluted earnings per share | Q2 FY2022 | $0.42 – $0.57 | New |
| Feb 3, 2022 | Diluted earnings per share | FY2022 | $2.50 – $3.00 | Lowered |
| Feb 3, 2022 | Gross margin percentages | Q2 FY2022 | 88.5% – 89.5% | New |
| Feb 3, 2022 | Gross margin percentages | Q2 FY2022 | 89.5% – 90.5% | New |
| Feb 3, 2022 | Operating margin percentages | FY2022 | 24% – 26% | Reaffirmed |
| Feb 3, 2022 | Operating margin percentages | FY2022 | 34% – 36% | Reaffirmed |
| Feb 3, 2022 | Effective tax rate | Q2 FY2022 | 19% – 20% | New |
| Feb 3, 2022 | Effective tax rate | Q2 FY2022 | 18% – 19% | New |
| Feb 3, 2022 | Operating expenses | Q2 FY2022 | $224.00M – $236.00M | New |
| Feb 3, 2022 | Operating expenses | Q2 FY2022 | $190.00M – $200.00M | New |
| Feb 3, 2022 | Operating expenses | FY2022 | $877.00M – $897.00M | Raised |
| Feb 3, 2022 | Operating expenses | FY2022 | $750.00M – $770.00M | Reaffirmed |
| Feb 3, 2022 | Total revenue | Q2 FY2022 | $315.00M – $345.00M | New |
| Feb 3, 2022 | Total revenue | FY2022 | $1.34B – $1.40B | Reaffirmed |
| Nov 16, 2021 | Diluted earnings per share | Q1 FY2022 | $0.98 – $1.13 | New |
| Nov 16, 2021 | Diluted earnings per share | FY2022 | $3.52 – $4.02 | New |
| Nov 16, 2021 | Diluted earnings per share | FY2022 | $2.53 – $3.03 | New |
| Nov 16, 2021 | Diluted earnings per share | Q1 FY2022 | $0.71 – $0.86 | New |
| Nov 16, 2021 | Gross margin percentages | Q1 FY2022 | 90% – 91% | New |
| Nov 16, 2021 | Gross margin percentages | Q1 FY2022 | 91% – 92% | New |
| Nov 16, 2021 | Operating margin percentages | FY2022 | 34% – 36% | New |
| Nov 16, 2021 | Operating margin percentages | FY2022 | 24% – 26% | New |
| Nov 16, 2021 | Effective tax rate | Q1 FY2022 | 18% – 19% | New |
| Nov 16, 2021 | Operating expenses | Q1 FY2022 | $221.00M – $231.00M | New |
| Nov 16, 2021 | Operating expenses | Q1 FY2022 | $190.00M – $200.00M | New |
| Nov 16, 2021 | Operating expenses | FY2022 | $869.00M – $889.00M | New |
| Nov 16, 2021 | Operating expenses | FY2022 | $750.00M – $770.00M | New |
| Nov 16, 2021 | Effective tax rate | Q1 FY2022 | 18% – 19% | New |
| Nov 16, 2021 | Total revenue | FY2022 | $1.34B – $1.40B | New |
| Nov 16, 2021 | Total revenue | Q1 FY2022 | $345.00M – $375.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Dolby Laboratories filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?